by Adam Strauss
Comedian Adam Strauss—who also happens to have obsessive-compulsive disorder—dives deep into the things that keep us hooked. Adam sits down with artists, academics, scientists and more to understand not only their obsessions, but the nature of obsession itself. Whether it’s a quirky hobby, an all-consuming career, or the relentless pursuit of knowledge, Obsessed with Adam Strauss peels back the layers of why we’re drawn to certain things—and what that reveals about who we are.
Language
🇺🇲
Publishing Since
12/5/2024
Email Addresses
0 available
Phone Numbers
0 available
December 23, 2024
In this eye-opening premiere of Obsessed with Adam Strauss, Adam sits down with Hamilton Morris—scientist, journalist, and creator of Hamilton’s Pharmacopeia—to uncover the shocking truth behind the FDA’s rejection of a groundbreaking psychedelic therapy. While many believe the decision stemmed from a lack of safety research, Hamilton reveals a far more sinister story: a covert effort by a small group to block this therapy’s approval through underhanded tactics and blatant dishonesty.Together, Adam and Hamilton unravel the conspiracy that’s putting lives and transformative science at risk. From the work of MAPS (Multidisciplinary Association for Psychedelic Studies) to the political and personal motives driving opposition to psychedelic therapy, this conversation explores how hidden agendas can shape public health policy and block life-changing treatments.If you think the story of psychedelic therapy is just about science and safety, think again. This episode digs deep into the power struggles, misinformation, and obsession behind one of the most controversial moments in this burgeoning movement.Topics Covered:The misconceptions surrounding the FDA’s rejection of psychedelic therapy.The covert efforts to block this therapy and their far-reaching implications.The role of capitalism, politics, and misinformation in the approval process.Why psychedelic therapy could revolutionize mental health treatment.Key Organizations discussed:MAPS - A nonprofit organization that developed the psychedelic therapy discussed in this episode and has led clinical trials to bring it to FDA approval. They previously sponsored Adam’s show The Mushroom Cure.Lykos Therapeutics - The for-profit pharmaceutical arm of MAPS.Compass Pathways - A for-profit company exploring psilocybin therapy, raising questions about the role of corporate interests in psychedelics. Hamilton used to consult for them.Psymposia - A media outlet that critically examines the psychedelic industry, including the ethical and political issues surrounding its development.Join the Obsession:If you enjoyed this episode, don’t forget to subscribe to Obsessed with Adam Strauss. Share this episode with friends, leave a review, and follow Adam on social media.Instagram: @atomstraussYouTube: AdamStraussTikTok: @atomstraussTwitter: @atomstraussAnd check out Adam's show The Mushroom Cure here.
December 5, 2024
Comedian Adam Strauss - who also happens to have obsessive-compulsive disorder - dives deep into the things that keep us hooked. Adam sits down with artists, academics, scientists and more to understand not only what they're obsessed with, but the nature of obsession itself. Whether it's a quirky hobby, an all-consuming career, or the relentless pursuit of knowledge, Obsessed with Adam Strauss peels back the layers of why we’re drawn to certain things—and what that reveals about who we are.
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at [email protected] for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.